123 related articles for article (PubMed ID: 37608419)
61. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
62. Neoadjuvant docetaxel, oxaliplatin and S‑1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction.
Saito T; Kurokawa Y; Takahashi T; Yamamoto K; Yamashita K; Tanaka K; Makino T; Nakajima K; Eguchi H; Doki Y
Gastric Cancer; 2022 Sep; 25(5):966-972. PubMed ID: 35488968
[TBL] [Abstract][Full Text] [Related]
63. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
[TBL] [Abstract][Full Text] [Related]
64. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
Al-Batran SE; Homann N; Pauligk C; Illerhaus G; Martens UM; Stoehlmacher J; Schmalenberg H; Luley KB; Prasnikar N; Egger M; Probst S; Messmann H; Moehler M; Fischbach W; Hartmann JT; Mayer F; Höffkes HG; Koenigsmann M; Arnold D; Kraus TW; Grimm K; Berkhoff S; Post S; Jäger E; Bechstein W; Ronellenfitsch U; Mönig S; Hofheinz RD
JAMA Oncol; 2017 Sep; 3(9):1237-1244. PubMed ID: 28448662
[TBL] [Abstract][Full Text] [Related]
65. Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.
Thompson SK; Bartholomeusz D; Devitt PG; Lamb PJ; Ruszkiewicz AR; Jamieson GG
Surg Endosc; 2011 Mar; 25(3):817-25. PubMed ID: 20725748
[TBL] [Abstract][Full Text] [Related]
66. [A Case of Unresectable Advanced Lower Esophageal Adenocarcinoma That Achieved Pathological Complete Response after Conversion Surgery following Nivolumab plus SOX Therapy].
Yamamichi K; Kotsuka M; Yoshida T; Hishikawa H; Mukaide H; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1765-1767. PubMed ID: 38303200
[TBL] [Abstract][Full Text] [Related]
67. Can we predict mediastinal lymph nodes metastasis in esophagogastric junction cancer? Results of a systematic review and meta-analysis.
Maatouk M; Ben Safta Y; Kbir GH; Mabrouk A; Ben Dhaou A; Daldoul S; Sayari S; Haouet K; Ben Moussa M
Gen Thorac Cardiovasc Surg; 2021 Aug; 69(8):1165-1173. PubMed ID: 34109538
[TBL] [Abstract][Full Text] [Related]
68. The optimal lymph node dissection in patients with adenocarcinoma of the esophagogastric junction.
Okholm C; Fjederholt KT; Mortensen FV; Svendsen LB; Achiam MP
Surg Oncol; 2018 Mar; 27(1):36-43. PubMed ID: 29549902
[TBL] [Abstract][Full Text] [Related]
69. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
[No Abstract] [Full Text] [Related]
70. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
71. [Short-term outcomes and long-term quality of life after undergoing radical proximal gastrectomy with esophageal gastric tube anastomosis and total gastrectomy with Roux-en-Y anastomosis for Siewert type II and III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis].
Xu ZW; Zhao K; Hong QQ; Chen YF; Wang HB; Lin HX; Wang TH; Xiao LB; Zhu JT; Yan S; You J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Feb; 26(2):181-190. PubMed ID: 36797565
[No Abstract] [Full Text] [Related]
72. Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
Kubo N; Yoshizawa J; Hanaoka T
BMC Cancer; 2018 Jun; 18(1):627. PubMed ID: 29866101
[TBL] [Abstract][Full Text] [Related]
73. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
74. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
75. Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG).
Shen J; Zhu X; Du Y; Zhu Y; Yu P; Yang L; Xu Z; Huang L; Zhang Y; Zhang Y; Liu L; Cheng X
Trials; 2021 Oct; 22(1):753. PubMed ID: 34717717
[TBL] [Abstract][Full Text] [Related]
76. ASO Author Reflections: Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
Shiraishi O
Ann Surg Oncol; 2020 Oct; 27(11):4441-4442. PubMed ID: 32451946
[No Abstract] [Full Text] [Related]
77. [A case of gastric cancer with abdominal paraaortic lymph node metastases responding to TS-1 plus CDDP neoadjuvant chemotherapy].
Yajima H; Kusuyama A; Fujita T; Nagayama A; Anazawa S; Yanaga K
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1583-5. PubMed ID: 15508455
[TBL] [Abstract][Full Text] [Related]
78. [A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin)].
Suematsu Y; Yamagishi S; Saito H; Takahashi M; Nakayama M; Fukabori M; Morita A; Wakabayashi K; Itoh Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2225-2227. PubMed ID: 28133277
[TBL] [Abstract][Full Text] [Related]
79. A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab.
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Ueda N; Takamura H; Kosaka T
Case Rep Oncol; 2020; 13(2):702-707. PubMed ID: 32774260
[TBL] [Abstract][Full Text] [Related]
80. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction.
Ulrich B; Zahedi A
Dis Esophagus; 2001; 14(2):115-9. PubMed ID: 11553220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
